Overview

A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults

Status:
Terminated

Trial end date:
2013-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to assess the pharmacokinetics (PK) and safety of a single dose of azilsartan medoxomil in children with hypertension, and comparative PK in healthy adults.

Phase:

Phase 1

Details

Lead Sponsor:

Takeda

Treatments:

Azilsartan medoxomil